Gaurav Shah
CEO · 8 filings · Latest: Aug 18, 2026
ROCKET PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RCKT | Gaurav Shah | CEO | Aug 18, 2026 | Sale | $3.38 | 2,293 | $7.8K | 1,056,594 | |
RCKT | Shah Gaurav | — | Aug 18, 2026 | Proposed Sale | $3.38 | 2,293 | $7.8K | — | |
RCKT | Gaurav Shah | CEO | Aug 13, 2026 | Sale | $3.38 | 2,837 | $9.6K | 1,058,887 | |
RCKT | Shah Gaurav | — | Aug 13, 2026 | Proposed Sale | $3.38 | 2,837 | $9.6K | — | |
RCKT | Gaurav Shah | CEO | May 21, 2026 | Sale | $3.09 | 55,684 | $171.8K | 1,061,724 | |
RCKT | Gaurav Shah | CEO | May 21, 2026 | Option Exercise | $1.69 | 76,490 | $129.3K | 1,117,408 | |
RCKT | Gaurav Shah | CEO | May 19, 2026 | Sale | $3.01 | 2,409 | $7.3K | 1,040,918 | |
RCKT | Shah Gaurav | — | May 21, 2026 | Proposed Sale | $3.09 | 55,684 | $171.8K | — | |
RCKT | Shah Gaurav | — | May 19, 2026 | Proposed Sale | $3.01 | 2,409 | $7.3K | — | |
RCKT | Gaurav Shah | CEO | May 13, 2026 | Sale | $3.61 | 2,728 | $9.8K | 1,043,327 | |
RCKT | Shah Gaurav | — | May 13, 2026 | Proposed Sale | $3.61 | 2,728 | $9.8K | — | |
RCKT | Gaurav Shah | CEO | Feb 18, 2026 | Sale | $3.34 | 5,990 | $20.0K | 1,046,055 | |
RCKT | Gaurav Shah | CEO | Feb 13, 2026 | Sale | $3.31 | 12,279 | $40.7K | 1,052,045 | |
RCKT | Shah Gaurav | — | Feb 18, 2026 | Proposed Sale | $3.34 | 5,990 | $20.0K | — | |
RCKT | Shah Gaurav | — | Feb 13, 2026 | Proposed Sale | $3.31 | 12,279 | $40.7K | — | |
RCKT | Shah Gaurav | — | Nov 18, 2025 | Proposed Sale | $2.98 | 6,276 | $18.7K | — | |
RCKT | Shah Gaurav | — | May 20, 2025 | Proposed Sale | $6.45 | 2,253 | $14.5K | — | |
RCKT | Shah Gaurav | — | May 16, 2025 | Proposed Sale | $6.53 | 3,621 | $23.6K | — | |
RCKT | Shah Gaurav | — | Feb 21, 2025 | Proposed Sale | $10.58 | 16,303 | $172.5K | — | |
RCKT | Shah Gaurav | — | Nov 21, 2024 | Proposed Sale | $13.05 | 11,091 | $144.8K | — |